- Home
- ACHV vs NMT Comparison
ACHV vs NMT Comparison
Compare ACHV & NMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHV
- NMT
- Stock Information
- Founded
- ACHV N/A
- NMT 1993
- Country
- ACHV United States
- NMT United States
- Employees
- ACHV N/A
- NMT N/A
- Industry
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- NMT Finance/Investors Services
- Sector
- ACHV Health Care
- NMT Finance
- Exchange
- ACHV Nasdaq
- NMT Nasdaq
- Market Cap
- ACHV 131.3M
- NMT 107.6M
- IPO Year
- ACHV N/A
- NMT N/A
- Fundamental
- Price
- ACHV $3.08
- NMT $11.62
- Analyst Decision
- ACHV Strong Buy
- NMT
- Analyst Count
- ACHV 2
- NMT 0
- Target Price
- ACHV $16.00
- NMT N/A
- AVG Volume (30 Days)
- ACHV 1.6M
- NMT 19.1K
- Earning Date
- ACHV 11-06-2025
- NMT 01-01-0001
- Dividend Yield
- ACHV N/A
- NMT 3.21%
- EPS Growth
- ACHV N/A
- NMT N/A
- EPS
- ACHV N/A
- NMT N/A
- Revenue
- ACHV N/A
- NMT N/A
- Revenue This Year
- ACHV N/A
- NMT N/A
- Revenue Next Year
- ACHV N/A
- NMT N/A
- P/E Ratio
- ACHV N/A
- NMT N/A
- Revenue Growth
- ACHV N/A
- NMT N/A
- 52 Week Low
- ACHV $1.84
- NMT $9.05
- 52 Week High
- ACHV $5.31
- NMT $10.93
- Technical
- Relative Strength Index (RSI)
- ACHV 56.04
- NMT 63.62
- Support Level
- ACHV $2.68
- NMT $11.14
- Resistance Level
- ACHV $3.30
- NMT $11.58
- Average True Range (ATR)
- ACHV 0.25
- NMT 0.11
- MACD
- ACHV 0.02
- NMT 0.04
- Stochastic Oscillator
- ACHV 49.38
- NMT 89.96
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About NMT Nuveen Massachusetts Quality Municipal Income Fund
Nuveen Massachusetts Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's objective seeks to provide current income exempt from both regular federal and Massachusetts income taxes and to enhance portfolio value relative to the Massachusetts municipal bond market by investing in tax-exempt Massachusetts municipal obligations that are underrated or undervalued or that represent municipal market sectors that are undervalued.